Skip to main content
. 2020 Sep 28;14:3983–3993. doi: 10.2147/DDDT.S264077

Figure 2.

Figure 2

The effect of compound 7594–0037 on cell viability and cell cycle. (A–B) Cell viability analysis of RPMI-8226 and U266 cells treated with different concentrations of compound 7594–0037. (C–D) RPMI-8226 and U266 cells were treated with compound 7594–0037 at different time intervals, and the CCK-8 assay was performed to determine the cell survival rate. (E–F) The distribution of RPMI-8226 and U266 cell subpopulations treated with compound 7594–0037 was analyzed by flow cytometry. The experiments were conducted at least three times. Error bars: mean ± SD; *P<0.05; **P<0.01; ***P<0.001.